Phase I Dose-escalation Study of Two Doses GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

Condition:   Influenza, Avian Interventions:   Biological: GHB04L1;   Other: Placebo Sponsor:   AVIR Green Hills Biotechnology AG Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials